ArticleJournal of clinical medicine2022

Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study.

Damian Mikulski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.